News

The dossier includes Generex Oral-lyn, the company’s proprietary oral insulin spray product that reportedly provides a safe, effective and pain-free alternative to subcutaneous injections of prandial insulin for

Sancuso was previously approved by the FDA as the first and only patch to provide up to five consecutive days of control of nausea and vomiting for patients

Prior to joining Accumetrics, Mr Dippel was vice president of operations at Barrx Medical. Mr Dippel holds a BS in mechanical engineering from the California State Polytechnic University,

HemaQuest has recently completed Phase I clinical trials of HQK-1001 in healthy subjects and plans to begin clinical studies of this compound in both sickle cell anemia and

The FDA approved Norditropin based on data from a 13-year clinical trial in children small for gestational age (SGA). The study showed that 63% of children who reached

The decision was made following a review of results by the company’s board of directors from the company’s ongoing UK Phase I and Phase II combination Reolysin and

Mylan and UCB Societe Anonyme and UCB Pharma have previously entered into an agreement to settle pending litigation relating to levetiracetam tablets. Pursuant to the settlement, Mylan was

The partnership with Therapure builds upon BioVectra’s expertise in the production of modified biologic molecules using a proprietary MPEG technology. Therapure, from its 130,000 square feet facilities in

Scheduled for completion by the end of 2009, the national reference laboratory (NRL) will be the first of its kind in the region to provide a centralized solution